Identification of HER2/neu-derived peptide epitopes recognized by gastric cancer-specific cytotoxic T lymphocytes

International Journal of Cancer

Volumn 78, Issue 2, 1998, Pages 202-208

  Kono, Koji ^a   Rongcun, Yang ^b,c   Charo, Jehad ^b,c   Ichihara, Fumiko ^a   Celis, Esteban ^d   Sette, Alessandro ^e   Appella, Ettore ^f   Sekikawa, Takayoshi ^a   Matsumoto, Yoshiro ^a   Kiessung, Rolf ^b,c  

^a UNIVERSITY OF YAMANASHI   (Japan)

^b KAROLINSKA INSTITUTE   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d MAYO GRADUATE SCHOOL   (United States)

^e CYTEL CORPORATION   (United States)

^f NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA A2 ANTIGEN;

ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; ARTICLE; CANCER IMMUNOTHERAPY; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN TISSUE; IMMUNOGENICITY; IMMUNOREGULATION; PRIORITY JOURNAL; STOMACH CANCER;

HLA-A2 ANTIGEN; HUMANS; IMMUNODOMINANT EPITOPES; LYMPHOCYTE ACTIVATION; LYMPHOCYTES, TUMOR-INFILTRATING; RECEPTOR, ERBB-2; SENSITIVITY AND SPECIFICITY; STOMACH NEOPLASMS; T-LYMPHOCYTES, CYTOTOXIC; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0031712512     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19981005)78:2<202::AID-IJC14>3.0.CO;2-C     Document Type: Article

References (21)

1. COUSSENS, L., YANG-FENG, L., LIAO, Y.C., CHEN, E., GRAY, A., MCGRATH, J., SEEBURG, P.H., LIBERMANN, T.A., SCHLESSINGER, J., FRANCKE, U., LEVINSON, A. and ULLRICH, A., Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene. Science, 230, 1132-1136 (1985).
2. Cox, A.L., SKIPPER, J., CHEN, Y., HENDERSON, R.A., DARROWS, T.L., SHABANOWITZ, J., ENGELHARD, V.H., HUNT, D.F. and SLINGLUFF, C.L., Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines. Science, 264, 716-719 (1994).
3. CROOKES, P., LEICHMAN, C.G., LEICHMAN, L., TAN, M., LAINE, L., STAIN, S., BARANDA, J., CASAGRANDE, Y., GROSHEN, S. and SILBERMAN, H., Systemic chemotherapy for gastric carcinoma followed by postoperative intraperitoneal therapy. Cancer, 79, 1767-1775 (1997).
4. FISK, B., BLEVINS, T.L., WHARTON, J.T. and IOANNIDES, C.G., Identification of an immunodominant peptide of HER-2/neu protooncogene recognized by ovarian tumor-specific cytotoxic T lymphocyte line. J. exp. Med., 181, 2109-2117 (1995).
5. HOSHINO, T., SEKI, N., KIKUCHI, M., KURAMOTO, T., IWAMOTO, O., KODAMA, I., KOUFUJI, K., TAKEDA, J. and ITOH, K., HLA class I-restricted and tumor-specific CTL in tumor-infiltrating lymphocytes of patients with gastric cancer. Int. J. Cancer, 70, 631-638 (1997).
6. IKEDA, H., SATO, N., MATSUURA, A. and KIKUTI, K., Analysis of T-cell receptor V region gene usage of cytotoxic T-lymphocytes and tumor-infiltrating lymphocytes derived from human autologous gastric signet ring-cell carcinoma. Cancer Res., 53, 3078-3084 (1993).
7. ISHIKAWA, T., KOBAYASHI, M., MAI, M., SUZUKI, T. and OOI, A., Amplification of the c-erbB-2 (HER2/neu) gene in gastric cancer cells. Detection by fluorescence in situ hybridization. Amer. J. Pathol., 151, 761-768 (1997).
8. KAWASHIMA, I., HUDSON, S.J., TSAI, V., SOUTHWOOD, S., TAKESAKO, K., APELLA, E., SETT, A. and CELIS, E., The multi-epitope approach for immunotherapy for cancer: identification of several CTL epitopes from various tumor associated antigens expressed on solid epithelial tumors. Hum. Immunol., in press (1998).
9. + T cell clones specific for the HER2/neu proto-oncogene expressed on ovarian carcinomas: related and unrelated to decreased MHC class I expression. Int. J. Cancer, 70, 112-119 (1997a).
10. + T cells derived from solid tumor, metastatic lymph nodes and ascites in patients with gastric cancer. Int. J. Cancer, 71, 978-981 (1997b).
11. LINEHAN, D.C., GOEDEGEBUURE, P.S., PEOPLE, G.E., ROGERS, S.O. and EBERLEIN, T.J., Tumor-specific and HLA-A2-restricted cytolysis by tumor-associated lymphocytes in human metastatic breast cancer. J. Immunol., 155, 4486-4491 (1995).
12. MAYORDOMO, J.I., ZORINA, T., STORKUS, W.J., ZITVOGEL, L., CELLUZZI, C., FALO, L.D., MELIEF, C.J., ILDSTAD, S.T., KAST, M.W., DELEO, A.B. and LOTZE, M.T., Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity. Nature (Med), 1, 1297-1302 (1995).
13. PEIPER, M., GOEDEGEBUURE, P.S., LINEMAN, D.C., GANGULY, E., DOUVILLE, C.C. and EBERLEIN, T.J., The HER2/neu-derived peptide p654-662 is a tumor-associated antigen in human pancreatic cancer recognised by cytotoxic T lymphocytes. Europ. J. Immunol., 27, 1115-1123 (1997).
14. ROSENBERG, S.A. and 15 OTHERS, Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. N. Engl. J. Med., 319, 1676-1680 (1988).
15. SALAZAR-ONFRAY, F., NAKAZAWA, T., CHHAJLANI, V., PETERSSON, M., KARRE, K., MASUCCI, G., CELIS, E., SETTE, A., SOUTHWOOD, S., APPELLA, E. and KIESSLING, R., Synthetic peptides derived from the melanocyte stimulating hormone receptor MC1R can stimulate HLA-A2 restricted CTL that recognize naturally processed peptides on human melanoma. Cancer Res., 57, 4348-4355 (1997).
16. SETTE, A., SIDNEY, J., DEL GUERCIO, M.F., SOUTHWOOD, S., RUPPERT, J., DAHLBERG, C., GREY, H.M. and KUBO, R.T., Peptide binding to the most frequent HLA-A class I alleles measured by quantitative molecular binding assays. Mol. Immunol., 31, 813-822 (1994).
17. SLAMON, D.J., GODOLPHIN, W., JONES, L.A., HOLT, J.A., WONG, S.G., KEITH, D.E., LEVIN, W.J., STUART, S.G., UDOVE, J., ULLRICH, A. and PRESS, M.F., Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science, 244, 707-712 (1989).
18. TRAVERSARI, C., VAN DER BRUGGEN, P., LEUSCHER, I.F., LURQUIN, C., CHOMEZ, P., VAN PEL, A., DE PLAEN, E., AMAR-COSTESEC, A. and BOON, T., A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E. J. exp. Med., 176, 1453-1457 (1992).
19. TSAI, V., SOUTHWOOD, S., SIDNEY, J., SAKAGUCHI, K., KAWAKAMI, Y., APELLA, E., SETTE, A. and CELIS, E., Identification of subdominant CTL epitopes of the gp 100 melanoma-associated tumor antigen by primary in vitro immunization with peptide-pulsed dendritic cells. J. Immunol., 158, 1796-1802 (1997).
20. YASOSHIMA, T., SATO, N., HIRATA, K. and KIKUCHI, K., The mechanism of human autologous gastric signet ring cell tumor rejection by cytotoxic T lymphocytes in the possible context of HLA-A31 molecule. Cancer, 75, 1484-1489 (1995).
21. YOSHINO, I., GOEDEGEBUURE, P.S., PEOPLES, G.E., PARIKH, A.S., DIMAIO, J.M., LYERLY, H.K., GAZDAR, A.F. and EBERLEIN, T.J., HER-2/neu-derived peptides are shared antigens among human non-small cell lung cancer and ovarian cancer. Cancer Res., 54, 3387-3390 (1994).